MedTrace Logo

A Study on Pain After Breast Reconstruction

NCT06627582 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 274

Last updated 2026-03-27

No results posted yet for this study

Summary

The purpose of this study is to find out how common persistent postmastectomy pain (PPMP) is among people who have had a mastectomy and breast reconstruction surgery for their breast cancer. The study will also look at how effective regenerative peripheral nerve interface (RPNI) surgery is for reducing pain from neuropathic PPMP after breast reconstruction.

Conditions

  • Mastectomy
  • Mastectomy Patient
  • Mastectomy and Breast Reconstruction
  • Breast Reconstruction
  • Breast Reconstruction After Mastectomy
  • Postmastectomy Pain

Interventions

BEHAVIORAL

PROMIS Scale v2.0 - Pain Intensity 3a

PROMIS Scale v2.0 - Pain Intensity 3a is a 3-question short form in which patients rate their worst, average, and current level of pain during the past 7 days.

BEHAVIORAL

PROMIS 29+2

PROMIS 29+2 (PROMIS-Preference, PROPr) is a compilation of item banks to assess pain intensity

BEHAVIORAL

PROMIS Scale v2.0 - Nociceptive Pain Quality 5a

5-question short form that identifies patients who have experienced nociceptive pain during the past 7 days

BEHAVIORAL

PROMIS Scale v2.0 - Neuropathic Pain Quality 5a

5-question short form that identifies patients who have experienced neuropathic pain during the past 7 days

Sponsors & Collaborators

Principal Investigators

  • Danielle Rochlin, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2027-10-01
Completion
2027-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06627582 on ClinicalTrials.gov